Follow
Raquel Fernanda Gerlach
Raquel Fernanda Gerlach
Professor of Histology and Molecular Biology, University of Sao Paulo, Campus of Ribeirao Preto
Verified email at forp.usp.br
Title
Cited by
Cited by
Year
A critical review of biomarkers used for monitoring human exposure to lead: advantages, limitations, and future needs
F Barbosa Jr, JE Tanus-Santos, RF Gerlach, PJ Parsons
Environmental health perspectives 113 (12), 1669-1674, 2005
8882005
Circulating interleukin‐6 and high‐sensitivity C‐reactive protein decrease after periodontal therapy in otherwise healthy subjects
AM Marcaccini, CA Meschiari, CA Sorgi, MCP Saraiva, AM de Souza, ...
Journal of periodontology 80 (4), 594-602, 2009
2382009
Protective effect of Calendula officinalis extract against UVB-induced oxidative stress in skin: Evaluation of reduced glutathione levels and matrix metalloproteinase secretion
YM Fonseca, CD Catini, FTMC Vicentini, A Nomizo, RF Gerlach, ...
Journal of ethnopharmacology 127 (3), 596-601, 2010
2262010
Gingival crevicular fluid levels of MMP‐8, MMP‐9, TIMP‐2, and MPO decrease after periodontal therapy
AM Marcaccini, CA Meschiari, LR Zuardi, TS De Sousa, M Taba Jr, ...
Journal of clinical periodontology 37 (2), 180-190, 2010
2152010
Metalloproteinase inhibition ameliorates hypertension and prevents vascular dysfunction and remodeling in renovascular hypertensive rats
MM Castro, E Rizzi, L Figueiredo-Lopes, K Fernandes, LM Bendhack, ...
Atherosclerosis 198 (2), 320-331, 2008
2102008
Inhibition of human gingival gelatinases (MMP-2 and MMP-9) by metal salts
AP De Souza, RF Gerlach, SRP Line
Dental Materials 16 (2), 103-108, 2000
1722000
Sex determination of human remains from peptides in tooth enamel
NA Stewart, RF Gerlach, RL Gowland, KJ Gron, J Montgomery
Proceedings of the National Academy of Sciences 114 (52), 13649-13654, 2017
1692017
Antioxidant treatment reduces matrix metalloproteinase-2-induced vascular changes in renovascular hypertension
MM Castro, E Rizzi, GJ Rodrigues, CS Ceron, LM Bendhack, RF Gerlach, ...
Free Radical Biology and Medicine 46 (9), 1298-1307, 2009
1662009
As organizações sociais de saúde como forma de gestão público/privado
NB Barbosa, PEM Elias
Ciência & Saúde Coletiva 15, 2483-2495, 2010
1622010
Comparative assessment of matrix metalloproteinase (MMP)-2 and MMP-9, and their inhibitors, tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in preeclampsia and …
ACT Palei, VC Sandrim, RC Cavalli, JE Tanus-Santos
Clinical Biochemistry 41 (10-11), 875-880, 2008
1412008
Rapid separation of serum does not avoid artificially higher matrix metalloproteinase (MMP)-9 levels in serum versus plasma
RF Gerlach, C Demacq, K Jung, JE Tanus-Santos
Clinical biochemistry 40 (1-2), 119-123, 2007
1412007
Effect of anticoagulants on the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities
RF Gerlach, JA Uzuelli, CD Souza-Tarla, JE Tanus-Santos
Analytical biochemistry 344 (1), 147-149, 2005
1372005
Methodological issues affecting the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities
CD Souza-Tarla, JA Uzuelli, AA Machado, RF Gerlach, JE Tanus-Santos
Clinical biochemistry 38 (5), 410-414, 2005
1352005
Imbalance between matrix metalloproteinases and tissue inhibitor of metalloproteinases in hypertensive vascular remodeling
MM Castro, E Rizzi, CM Prado, MA Rossi, JE Tanus-Santos, RF Gerlach
Matrix Biology 29 (3), 194-201, 2010
1312010
Circulating matrix metalloproteinase-8 (MMP-8) and MMP-9 are increased in chronic periodontal disease and decrease after non-surgical periodontal therapy
AM Marcaccini, AB Novaes Jr, CA Meschiari, SL Souza, DB Palioto, ...
Clinica chimica acta 409 (1-2), 117-122, 2009
1242009
Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome
FM Gonçalves, ALB Jacob-Ferreira, VA Gomes, A Casella-Filho, ...
Clinica Chimica Acta 403 (1-2), 173-177, 2009
1192009
Increased activities of cardiac matrix metalloproteinases matrix metalloproteinase (MMP)-2 and MMP-9 are associated with mortality during the acute phase of experimental …
FRS Gutierrez, MM Lalu, FS Mariano, CM Milanezi, C Jonathan, ...
The Journal of infectious diseases 197 (10), 1468-1476, 2008
1172008
Matrix metalloproteinases: targets for doxycycline to prevent the vascular alterations of hypertension
MM Castro, JE Tanus-Santos, RF Gerlach
Pharmacological research 64 (6), 567-572, 2011
1102011
Lercanidipine reduces matrix metalloproteinase-9 activity in patients with hypertension
MLL Martinez, LF Lopes, EB Coelho, F Nobre, JBT Rocha, RF Gerlach, ...
Journal of cardiovascular pharmacology 47 (1), 117-122, 2006
1092006
Circulating matrix metalloproteinases and their inhibitors in hypertension
V Fontana, PS Silva, RF Gerlach, JE Tanus-Santos
Clinica Chimica Acta 413 (7-8), 656-662, 2012
1082012
The system can't perform the operation now. Try again later.
Articles 1–20